PhRMA PUTS TOGETHER Ex-FDA COMMISSIONER GROUP TO PROVIDE SUGGESTIONS FOR AGENCY CHANGES; FORMER REP. ROGERS HEADS EFFORT TO DEVELOP MODERATE REFORMS
The Pharmaceutical Research & Manufacturers of America is working with a group of former FDA commissioners to prepare suggested reforms for the agency. The informal advisory group is understood to have enlisted at least three former commissioners: Charles Edwards, MD (former chairman of the Scripps Research Center); Mark Novitch, MD (recently retired from Upjohn and president of the U.S. Pharmacopeia); and Jere Goyan, PhD (president of Alteon Corp.).
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth